We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+14.27%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$12.2M
(+5%)
Cap. Flow
-$3.63M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
47.16%
Holding
248
New
79
Increased
35
Reduced
67
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.6M |
| 2 |
EOG Resources
EOG
|
+$2.56M |
| 3 |
Chevron
CVX
|
+$2.51M |
| 4 |
Kenvue
KVUE
|
+$1.8M |
| 5 |
NextEra Energy
NEE
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$3M |
| 2 |
PPG Industries
PPG
|
+$2.06M |
| 3 |
Colgate-Palmolive
CL
|
+$1.74M |
| 4 |
McDonald's
MCD
|
+$1.67M |
| 5 |
RTX Corp
RTX
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.62% |
| 2 | Technology | 17.66% |
| 3 | Financials | 12.3% |
| 4 | Healthcare | 9.75% |
| 5 | Energy | 5.49% |
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Alpha DNA Investment Management held 248 positions worth $256M, up 5% from $244M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Alpha DNA Investment Management's Q4 2023 filing shows 79 new, 35 increased, 67 reduced and 65 closed positions. Its largest new stake was Kenvue: 89,868 shares worth $1.93M. The largest sale was Eli Lilly, an estimated $3M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
- Alpha DNA Investment Management's largest Q4 2023 buy was Kenvue: 89,868 shares worth $1.93M.
- Alpha DNA Investment Management added most to Microsoft in Q4 2023, an estimated $2.6M increase.
- Alpha DNA Investment Management's biggest Q4 2023 reduction was PPG Industries, cutting an estimated $2.06M.
- Alpha DNA Investment Management fully exited Eli Lilly in Q4 2023, selling an estimated $3M.
- Alpha DNA Investment Management's ten largest holdings make up 47% of its $256M portfolio in Q4 2023.
- Alpha DNA Investment Management opened 79 new positions and closed 65 in Q4 2023.
- Alpha DNA Investment Management's portfolio value rose 5% quarter-over-quarter to $256M.
Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.